12 studies were found.

1.		No longer recruiting	CHS 828 in Treating Patients With Solid Tumors Condition: unspecified adult solid tumor, protocol specific
2.		No longer recruiting	Comparison of Two Regimens of Liposomal Doxorubicin in Treating Women with Metastatic Breast Cancer Conditions: stage IV breast cancer; recurrent breast cancer
3.		No longer recruiting	E7070 in Treating Patients With Solid Tumors Condition: unspecified adult solid tumor, protocol specific
4.		No longer recruiting	Halofuginone Hydrobromide in Treating Patients With Progressive Advanced Solid Tumors Condition: unspecified adult solid tumor, protocol specific
5.		No longer recruiting	MEN-10755 in Treating Patients With Progressive Prostate Cancer That Has Not Responded to Hormone Therapy Conditions: adenocarcinoma of the prostate; recurrent prostate cancer
6.		Recruiting	Mistletoe Lectin in Treating Patients With Advanced Solid Tumors That Have Not Responded to Previous Therapy Condition: unspecified adult solid tumor, protocol specific
7.		No longer recruiting	Mistletoe Lectin in Treating Patients With Refractory Advanced Solid Tumors Condition: unspecified adult solid tumor, protocol specific
8.		No longer recruiting	MS 209 Plus Docetaxel in Treating Patients With Advanced Solid Tumors Condition: unspecified adult solid tumor, protocol specific
9.		No longer recruiting	Nitrocamptothecin in Treating Patients With Advanced Ovarian Cancer Conditions: stage III ovarian epithelial cancer; stage IV ovarian epithelial cancer; recurrent ovarian epithelial cancer
10.		No longer recruiting	Oxaliplatin in Treating Women With Advanced or Metastatic Breast Cancer That Has Not Responded to Previous Chemotherapy Conditions: stage III breast cancer; stage IV breast cancer; recurrent breast cancer
11.		No longer recruiting	R101933 Combined With Chemotherapy in Treating Patients With Metastatic Breast Cancer That Has Not Responded to Previous Chemotherapy Conditions: stage IV breast cancer; recurrent breast cancer
12.		No longer recruiting	SCH 66336 Plus Gemcitabine in Treating Patients With Advanced Cancer of the Urinary Tract Conditions: recurrent bladder cancer; stage IV bladder cancer; transitional cell carcinoma of the bladder; recurrent urethral cancer; anterior urethral cancer; ...